Virtus ETF Advisers’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,789
| Closed | -$280K | – | 680 |
|
|
2024
Q4 | $280K | Buy |
35,789
+8,457
| +31% | +$66.2K | 0.11% | 251 |
|
|
2024
Q3 | $359K | Hold |
27,332
| – | – | 0.17% | 212 |
|
|
2024
Q2 | $330K | Buy |
+27,332
| New | +$330K | 0.16% | 211 |
|
|
2022
Q2 | – | Sell |
-23,646
| Closed | -$281K | – | 479 |
|
|
2022
Q1 | $281K | Hold |
23,646
| – | – | 0.13% | 180 |
|
|
2021
Q4 | $383K | Buy |
23,646
+11,068
| +88% | +$179K | 0.14% | 169 |
|
|
2021
Q3 | $359K | Sell |
12,578
-1,150
| -8% | -$32.8K | 0.16% | 184 |
|
|
2021
Q2 | $464K | Buy |
13,728
+1,735
| +14% | +$58.6K | 0.19% | 173 |
|
|
2021
Q1 | $363K | Buy |
11,993
+331
| +3% | +$10K | 0.15% | 201 |
|
|
2020
Q4 | $577K | Buy |
11,662
+4,353
| +60% | +$215K | 0.24% | 125 |
|
|
2020
Q3 | $281K | Sell |
7,309
-1,000
| -12% | -$38.4K | 0.15% | 238 |
|
|
2020
Q2 | $359K | Sell |
8,309
-3,023
| -27% | -$131K | 0.17% | 255 |
|
|
2020
Q1 | $296K | Sell |
11,332
-1,671
| -13% | -$43.6K | 0.12% | 223 |
|
|
2019
Q4 | $406K | Buy |
+13,003
| New | +$406K | 0.07% | 249 |
|